You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Pulmonary Toxicities Associated With the Use of Immune Checkpoint Inhibitors: An Update From the Immuno-Oncology Subgroup of the Neutropenia, Infection & Myelosuppression Study Group of the Multinational Association for Supportive Care in Cancer
|
|---|---|
| Published in |
Frontiers in Pharmacology, October 2021
|
| DOI | 10.3389/fphar.2021.743582 |
| Pubmed ID | |
| Authors |
Bernardo L. Rapoport, Vickie R. Shannon, Tim Cooksley, Douglas B. Johnson, Lindsay Anderson, Ada G. Blidner, Gregory R. Tintinger, Ronald Anderson |
X Demographics
The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 1 | 20% |
| Colombia | 1 | 20% |
| Italy | 1 | 20% |
| Switzerland | 1 | 20% |
| Unknown | 1 | 20% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 4 | 80% |
| Scientists | 1 | 20% |
Mendeley readers
The data shown below were compiled from readership statistics for 35 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 35 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Other | 4 | 11% |
| Student > Doctoral Student | 3 | 9% |
| Student > Bachelor | 3 | 9% |
| Researcher | 3 | 9% |
| Professor > Associate Professor | 2 | 6% |
| Other | 5 | 14% |
| Unknown | 15 | 43% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 13 | 37% |
| Biochemistry, Genetics and Molecular Biology | 2 | 6% |
| Economics, Econometrics and Finance | 2 | 6% |
| Environmental Science | 1 | 3% |
| Neuroscience | 1 | 3% |
| Other | 0 | 0% |
| Unknown | 16 | 46% |
Attention Score in Context
This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 October 2023.
All research outputs
#15,029,384
of 25,163,621 outputs
Outputs from Frontiers in Pharmacology
#4,968
of 19,325 outputs
Outputs of similar age
#200,159
of 428,697 outputs
Outputs of similar age from Frontiers in Pharmacology
#229
of 1,064 outputs
Altmetric has tracked 25,163,621 research outputs across all sources so far. This one is in the 38th percentile – i.e., 38% of other outputs scored the same or lower than it.
So far Altmetric has tracked 19,325 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.3. This one has gotten more attention than average, scoring higher than 73% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 428,697 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 51% of its contemporaries.
We're also able to compare this research output to 1,064 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 77% of its contemporaries.